
IQVIA Holdings IQV
€ 146.50
-0.97%
Geschäftsbericht 2025
hinzugefügt 17.02.2026
IQVIA Holdings P/B 2011-2026 | IQV
P/B Jährlich IQVIA Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.27 | 5.88 | 7.26 | 7.38 | 7.76 | 5.42 | 4.89 | 3.74 | 2.72 | 1.27 | -22.3 | -11 | -8.87 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.76 | -22.3 | 0.647 |
P/B anderer Aktien in der Diagnostik & Forschung
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
7.78 | $ 113.86 | -0.85 % | $ 34.6 B | ||
|
Danaher Corporation
DHR
|
1.79 | $ 190.59 | -0.8 % | $ 136 B | ||
|
DexCom
DXCM
|
9.29 | $ 63.64 | 0.68 % | $ 24.8 B | ||
|
Fulgent Genetics
FLGT
|
0.413 | $ 16.32 | -0.61 % | $ 493 M | ||
|
Guardant Health
GH
|
-135 | $ 90.59 | 1.04 % | $ 11.4 B | ||
|
ICON Public Limited Company
ICLR
|
1.74 | $ 107.81 | -1.66 % | $ 8.89 B | ||
|
Illumina
ILMN
|
2.6 | $ 127.23 | -0.4 % | $ 20.2 B | ||
|
CareDx, Inc
CDNA
|
3.28 | $ 17.63 | -1.07 % | $ 939 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
1.97 | - | - | $ 562 M | ||
|
Laboratory Corporation of America Holdings
LH
|
2.77 | $ 274.85 | 0.14 % | $ 22.9 B | ||
|
Lantheus Holdings
LNTH
|
4.7 | $ 75.68 | -0.28 % | $ 5.11 B | ||
|
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M | ||
|
Medpace Holdings
MEDP
|
28.2 | $ 493.63 | -0.48 % | $ 14.2 B | ||
|
Burning Rock Biotech Limited
BNR
|
1.22 | $ 16.99 | 4.23 % | $ 176 M | ||
|
Myriad Genetics
MYGN
|
1.11 | $ 4.62 | -1.07 % | $ 428 M | ||
|
Co-Diagnostics
CODX
|
0.284 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
NeoGenomics
NEO
|
1.77 | $ 7.98 | -0.5 % | $ 1.02 B | ||
|
Aspira Women's Health
AWH
|
6.75 | - | -6.19 % | $ 10.5 M | ||
|
Neogen Corporation
NEOG
|
0.492 | $ 9.93 | 3.82 % | $ 2.15 B | ||
|
Natera
NTRA
|
7.52 | $ 207.69 | 1.38 % | $ 20.4 B | ||
|
Accelerate Diagnostics
AXDX
|
-1.81 | - | -61.36 % | $ 2.46 M | ||
|
National Research Corporation
NRC
|
22.5 | $ 17.24 | -0.52 % | $ 386 M | ||
|
Pacific Biosciences of California
PACB
|
93.1 | $ 1.4 | -1.76 % | $ 420 M | ||
|
Global Cord Blood Corporation
CO
|
0.0498 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
561 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.28 | - | 0.12 % | $ 80.1 M | ||
|
Precipio
PRPO
|
2.63 | $ 26.0 | 0.08 % | $ 41.7 M | ||
|
Personalis
PSNL
|
1.25 | $ 6.21 | -5.57 % | $ 368 M | ||
|
Charles River Laboratories International
CRL
|
2.4 | $ 167.8 | -0.25 % | $ 8.32 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | ||
|
Sotera Health Company
SHC
|
7.84 | $ 14.86 | -0.1 % | $ 4.22 B | ||
|
Castle Biosciences
CSTL
|
1.56 | $ 24.96 | 0.93 % | $ 693 M | ||
|
Soleno Therapeutics
SLNO
|
4.63 | $ 52.25 | - | $ 2.66 B | ||
|
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | ||
|
Neuronetics
STIM
|
3.09 | $ 1.6 | -9.09 % | $ 106 M | ||
|
Biodesix
BDSX
|
4.41 | $ 14.71 | -4.21 % | $ 1.91 B | ||
|
Koninklijke Philips N.V.
PHG
|
0.995 | $ 26.99 | -0.79 % | $ 20 B | ||
|
Thermo Fisher Scientific
TMO
|
1.78 | $ 483.56 | -0.95 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
-375 | $ 0.61 | -1.34 % | $ 61.9 M | ||
|
VolitionRx Limited
VNRX
|
-0.707 | $ 0.17 | -0.89 % | $ 21.4 M | ||
|
Waters Corporation
WAT
|
7.68 | $ 301.9 | -0.72 % | $ 18 B | ||
|
QIAGEN N.V.
QGEN
|
1.84 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
0.00742 | $ 2.59 | - | $ 84.1 K | ||
|
Biomerica
BMRA
|
1.75 | $ 2.08 | -4.13 % | $ 4.78 M | ||
|
BioNano Genomics
BNGO
|
0.179 | $ 1.14 | -1.3 % | $ 6.21 M | ||
|
Interpace Biosciences
IDXG
|
0.328 | $ 2.02 | 2.54 % | $ 8.94 M | ||
|
Check-Cap Ltd.
CHEK
|
-2.99 | - | - | $ 9.42 M | ||
|
Celcuity
CELC
|
53.4 | $ 113.87 | -0.31 % | $ 5.32 B |